![](/img/cover-not-exists.png)
Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases
Freedman, R. A., Gelman, R. S., Wefel, J. S., Melisko, M. E., Hess, K. R., Connolly, R. M., Van Poznak, C. H., Niravath, P. A., Puhalla, S. L., Ibrahim, N., Blackwell, K. L., Liu, M. C., Lowe, A., AgaLanguage:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2015.63.0343
Date:
February, 2016
File:
PDF, 699 KB
english, 2016